Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 23706777)

1.

Drops of madness? Recreational misuse of tropicamide collyrium; early warning alerts from Russia and Italy.

Bersani FS, Corazza O, Simonato P, Mylokosta A, Levari E, Lovaste R, Schifano F.

Gen Hosp Psychiatry. 2013 Sep-Oct;35(5):571-3. doi: 10.1016/j.genhosppsych.2013.04.013. Epub 2013 May 23.

PMID:
23706777
2.

Injecting eye-drops: a mini-review on the non-clinical use of tropicamide.

Bersani FS, Imperatori C, Prilutskaya M, Kuliev R, Corazza O.

Hum Psychopharmacol. 2015 Jul;30(4):262-4. doi: 10.1002/hup.2481.

PMID:
26216560
3.

From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine.

Corazza O, Assi S, Schifano F.

CNS Neurosci Ther. 2013 Jun;19(6):454-60. doi: 10.1111/cns.12063. Epub 2013 Feb 20. Review.

PMID:
23421859
4.

Intravenous Abuse of Tropicamide in Opioid Use Disorder: Presentation of 2 Cases.

Bozkurt M, Karabulut V, Evren C, Seker M, Kan H.

Subst Abus. 2015;36(2):170-3. doi: 10.1080/08897077.2014.924465. Epub 2014 Jun 3.

PMID:
24892477
5.

The diffusion of performance and image-enhancing drugs (PIEDs) on the internet: the abuse of the cognitive enhancer piracetam.

Corazza O, Bersani FS, Brunoro R, Valeriani G, Martinotti G, Schifano F.

Subst Use Misuse. 2014 Dec;49(14):1849-56. doi: 10.3109/10826084.2014.912232. Epub 2014 May 14.

PMID:
24827869
6.

Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project.

Corazza O, Assi S, Simonato P, Corkery J, Bersani FS, Demetrovics Z, Stair J, Fergus S, Pezzolesi C, Pasinetti M, Deluca P, Drummond C, Davey Z, Blaszko U, Moskalewicz J, Mervo B, Furia LD, Farre M, Flesland L, Pisarska A, Shapiro H, Siemann H, Skutle A, Sferrazza E, Torrens M, Sambola F, van der Kreeft P, Scherbaum N, Schifano F.

Hum Psychopharmacol. 2013 Jul;28(4):317-23. doi: 10.1002/hup.2299.

PMID:
23881879
7.

Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey.

Simonato P, Corazza O, Santonastaso P, Corkery J, Deluca P, Davey Z, Blaszko U, Schifano F.

Hum Psychopharmacol. 2013 Jul;28(4):324-31. doi: 10.1002/hup.2300.

PMID:
23881880
8.

Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project.

Deluca P, Davey Z, Corazza O, Di Furia L, Farre M, Flesland LH, Mannonen M, Majava A, Peltoniemi T, Pasinetti M, Pezzolesi C, Scherbaum N, Siemann H, Skutle A, Torrens M, van der Kreeft P, Iversen E, Schifano F.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):221-6. doi: 10.1016/j.pnpbp.2012.07.011. Epub 2012 Jul 27.

PMID:
22841965
9.

New drugs on the Internet: the case of Camfetamine.

Cinosi E, Corazza O, Santacroce R, Lupi M, Acciavatti T, Martinotti G, di Giannantonio M.

Biomed Res Int. 2014;2014:419026. doi: 10.1155/2014/419026. Epub 2014 Jul 16. Review.

10.

Polydrug abuse by intravenous use of heroin and tropicamide-containing eyedrops.

Spagnolo PA, Badiani A, Nencini P.

Clin Neuropharmacol. 2013 May-Jun;36(3):100-1. doi: 10.1097/WNF.0b013e31828da20e.

PMID:
23673915
11.

Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY.

Wood DM, Looker JJ, Shaikh L, Button J, Puchnarewicz M, Davies S, Lidder S, Ramsey J, Holt DW, Dargan PI.

J Med Toxicol. 2009 Dec;5(4):226-9.

12.

Olanzapine as the ideal "trip terminator"? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms.

Valeriani G, Corazza O, Bersani FS, Melcore C, Metastasio A, Bersani G, Schifano F.

Hum Psychopharmacol. 2015 Jul;30(4):249-54. doi: 10.1002/hup.2431.

PMID:
26216558
13.

The "Eyeballing" technique: an emerging and alerting trend of alcohol misuse.

Bersani FS, Corazza O, Albano G, Bruschi S, Minichino A, Vicinanza R, Bersani G, Martinotti G, Schifano F.

Eur Rev Med Pharmacol Sci. 2015 Jun;19(12):2311-7.

14.

Profiling online recreational/prescription drugs' customers and overview of drug vending virtual marketplaces.

Orsolini L, Francesconi G, Papanti D, Giorgetti A, Schifano F.

Hum Psychopharmacol. 2015 Jul;30(4):302-18. doi: 10.1002/hup.2466.

PMID:
26216567
15.

Breaking worse: the emergence of krokodil and excessive injuries among people who inject drugs in Eurasia.

Grund JP, Latypov A, Harris M.

Int J Drug Policy. 2013 Jul;24(4):265-74. doi: 10.1016/j.drugpo.2013.04.007. Epub 2013 May 31. Review.

PMID:
23726898
16.

Cycloplegia in African-American children.

Kleinstein RN, Mutti DO, Manny RE, Shin JA, Zadnik K.

Optom Vis Sci. 1999 Feb;76(2):102-7.

PMID:
10082056
17.

Quality of online pharmacies and websites selling prescription drugs: a systematic review.

Orizio G, Merla A, Schulz PJ, Gelatti U.

J Med Internet Res. 2011 Sep 30;13(3):e74. doi: 10.2196/jmir.1795. Review.

18.

25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug.

Bersani FS, Corazza O, Albano G, Valeriani G, Santacroce R, Bolzan Mariotti Posocco F, Cinosi E, Simonato P, Martinotti G, Bersani G, Schifano F.

Biomed Res Int. 2014;2014:734749. doi: 10.1155/2014/734749. Epub 2014 Jul 3. Review.

19.

Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.

Moratti E, Kashanpour H, Lombardelli T, Maisto M.

Clin Drug Investig. 2010;30 Suppl 1:3-11. doi: 10.2165/11536020-000000000-00000.

PMID:
20450240
20.

The availability and portrayal of stimulants over the Internet.

Schepis TS, Marlowe DB, Forman RF.

J Adolesc Health. 2008 May;42(5):458-65. doi: 10.1016/j.jadohealth.2007.11.140. Epub 2008 Mar 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk